-
1
-
-
54849146600
-
Hepatitis B virus infection
-
Dienstag JL. 2008. Hepatitis B virus infection. N Engl J Med 359:1486-1500. http://dx.doi.org/10.1056/NEJMra0801644.
-
(2008)
N Engl J Med
, vol.359
, pp. 1486-1500
-
-
Dienstag, J.L.1
-
2
-
-
84922474770
-
Gene therapeutic approaches to inhibit hepatitis B virus replication
-
Gebbing M, Bergmann T, Schulz E., Ehrhardt A. 2015. Gene therapeutic approaches to inhibit hepatitis B virus replication. World J Hepatol 7:150-164. http://dx.doi.org/10.4254/wjh.v7.i2.150.
-
(2015)
World J Hepatol
, vol.7
, pp. 150-164
-
-
Gebbing, M.1
Bergmann, T.2
Schulz, E.3
Ehrhardt, A.4
-
3
-
-
78349236621
-
Review of hepatitis B therapeutics
-
Bhattacharya D, Thio CL 2010. Review of hepatitis B therapeutics. Clin Infect Dis 51:1201-1208. http://dx.doi.org/10.1086/656624.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 1201-1208
-
-
Bhattacharya, D.1
Thio, C.L.2
-
4
-
-
59749096640
-
Hepatitis B virus infection
-
Liaw YF, Chu CM 2009. Hepatitis B virus infection. Lancet 373:582-592. http://dx.doi.org/10.1016/S0140-6736(09)60207-5.
-
(2009)
Lancet
, vol.373
, pp. 582-592
-
-
Liaw, Y.F.1
Chu, C.M.2
-
5
-
-
77957311078
-
Discovery and development of anti-HBV agents and their resistance
-
Kim KH, Kim ND, Seong BL 2010. Discovery and development of anti-HBV agents and their resistance. Molecules 15:5878-5908. http://dx.doi.org/10.3390/molecules15095878.
-
(2010)
Molecules
, vol.15
, pp. 5878-5908
-
-
Kim, K.H.1
Kim, N.D.2
Seong, B.L.3
-
6
-
-
84923163857
-
The interface between HBV capsid proteins affects self-assembly, pgRNA packaging, and reverse transcription
-
Tan Z, Pionek K, Unchwaniwala N., Maguire ML, Loeb DD, Zlotnick A. 2015. The interface between HBV capsid proteins affects self-assembly, pgRNA packaging, and reverse transcription. J Virol http://dx.doi.org/10.1128/JVI.03545-14.
-
(2015)
J Virol
-
-
Tan, Z.1
Pionek, K.2
Unchwaniwala, N.3
Maguire, M.L.4
Loeb, D.D.5
Zlotnick, A.6
-
7
-
-
0029950758
-
Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein
-
Zlotnick A, Cheng N, Conway J.F., Booy FP, Steven AC, Stahl SJ, Wingfield PT 1996. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35: 7412-7421. http://dx.doi.org/10.1021/bi9604800.
-
(1996)
Biochemistry
, vol.35
, pp. 7412-7421
-
-
Zlotnick, A.1
Cheng, N.2
Conway, J.F.3
Booy, F.P.4
Steven, A.C.5
Stahl, S.J.6
Wingfield, P.T.7
-
8
-
-
1842409555
-
Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy
-
Böttcher B., Wynne SA, Crowther RA 1997. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386:88-91. http://dx.doi.org/10.1038/386088a0.
-
(1997)
Nature
, vol.386
, pp. 88-91
-
-
Böttcher, B.1
Wynne, S.A.2
Crowther, R.A.3
-
9
-
-
78651384693
-
The arginine clusters of the carboxyterminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication
-
Lewellyn EB, Loeb DD 2011. The arginine clusters of the carboxyterminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J Virol 85:1298-1309. http://dx.doi.org/10.1128/JVI.01957-10.
-
(2011)
J Virol
, vol.85
, pp. 1298-1309
-
-
Lewellyn, E.B.1
Loeb, D.D.2
-
10
-
-
84881478439
-
Assemblydirected antivirals differentially bind quasi-equivalent pockets to modify HBV capsid tertiary and quaternary structure
-
Katen SP, Tan Z, Chirapu S.R., Finn MG, Zlotnick A. 2013. Assemblydirected antivirals differentially bind quasi-equivalent pockets to modify HBV capsid tertiary and quaternary structure. Structure 21:1406-1416. http://dx.doi.org/10.1016/j.str.2013.06.013.
-
(2013)
Structure
, vol.21
, pp. 1406-1416
-
-
Katen, S.P.1
Tan, Z.2
Chirapu, S.R.3
Finn, M.G.4
Zlotnick, A.5
-
11
-
-
84874698351
-
Genetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture
-
Tan Z, Maguire ML, Loeb D.D., Zlotnick A. 2013. Genetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture. J Virol 87:3208-3216. http://dx.doi.org/10.1128/JVI.03014-12.
-
(2013)
J Virol
, vol.87
, pp. 3208-3216
-
-
Tan, Z.1
Maguire, M.L.2
Loeb, D.D.3
Zlotnick, A.4
-
12
-
-
84874031889
-
Phase diagrams map the properties of antiviral agents directed against hepatitis B virus core assembly
-
Li L, Chirapu SR, Finn M.G., Zlotnick A. 2013. Phase diagrams map the properties of antiviral agents directed against hepatitis B virus core assembly. Antimicrob Agents Chemother 57:1505-1508. http://dx.doi.org/10.1128/AAC.01766-12.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1505-1508
-
-
Li, L.1
Chirapu, S.R.2
Finn, M.G.3
Zlotnick, A.4
-
13
-
-
33845868485
-
BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly
-
Stray SJ, Zlotnick A. 2006. BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly. J Mol Recognit 19:542-548. http://dx.doi.org/10.1002/jmr.801.
-
(2006)
J Mol Recognit
, vol.19
, pp. 542-548
-
-
Stray, S.J.1
Zlotnick, A.2
-
14
-
-
0347928672
-
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
-
Deres K, Schroder CH, Paessens A, Goldmann S., Hacker HJ, Weber O, Kramer T, Niewohner U., Pleiss U, Stoltefuss J, Graef E., Koletzki D, Masantschek RN, Reimann A, Jaeger R., Gross R, Beckermann B, Schlemmer KH, Haebich D, Rubsamen-Waigmann H. 2003. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 299: 893-896. http://dx.doi.org/10.1126/science.1077215.
-
(2003)
Science
, vol.299
, pp. 893-896
-
-
Deres, K.1
Schroder, C.H.2
Paessens, A.3
Goldmann, S.4
Hacker, H.J.5
Weber, O.6
Kramer, T.7
Niewohner, U.8
Pleiss, U.9
Stoltefuss, J.10
Graef, E.11
Koletzki, D.12
Masantschek, R.N.13
Reimann, A.14
Jaeger, R.15
Gross, R.16
Beckermann, B.17
Schlemmer, K.H.18
Haebich, D.19
Rubsamen-Waigmann, H.20
more..
-
15
-
-
53749103127
-
Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle
-
Bourne C, Lee S, Venkataiah B., Lee A, Korba B, Finn M.G., Zlotnick A. 2008. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle. J Virol 82:10262-10270. http://dx.doi.org/10.1128/JVI.01360-08.
-
(2008)
J Virol
, vol.82
, pp. 10262-10270
-
-
Bourne, C.1
Lee, S.2
Venkataiah, B.3
Lee, A.4
Korba, B.5
Finn, M.G.6
Zlotnick, A.7
-
16
-
-
20444421508
-
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
-
Stray SJ, Bourne CR, Punna S, Lewis W.G., Finn MG, Zlotnick A. 2005. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc Natl Acad Sci U S A 102:8138-8143. http://dx.doi.org/10.1073/pnas.0409732102.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 8138-8143
-
-
Stray, S.J.1
Bourne, C.R.2
Punna, S.3
Lewis, W.G.4
Finn, M.G.5
Zlotnick, A.6
-
17
-
-
0036227850
-
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound ina transgenic mouse model
-
Weber O, Schlemmer KH, Hartmann E, Hagelschuer I., Paessens A, Graef E, Deres K., Goldmann S, Niewoehner U, Stoltefuss J., Haebich D, Ruebsamen-Waigmann H, Wohlfeil S. 2002. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound ina transgenic mouse model. Antiviral Res 54:69-78. http://dx.doi.org/10.1016/S0166-3542(01)00216-9.
-
(2002)
Antiviral Res
, vol.54
, pp. 69-78
-
-
Weber, O.1
Schlemmer, K.H.2
Hartmann, E.3
Hagelschuer, I.4
Paessens, A.5
Graef, E.6
Deres, K.7
Goldmann, S.8
Niewoehner, U.9
Stoltefuss, J.10
Haebich, D.11
Ruebsamen-Waigmann, H.12
Wohlfeil, S.13
-
18
-
-
34548641466
-
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
-
Feld JJ, Colledge D, Sozzi V., Edwards R, Littlejohn M, Locarnini SA 2007. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging. Antiviral Res 76:168-177. http://dx.doi.org/10.1016/j.antiviral.2007.06.014.
-
(2007)
Antiviral Res
, vol.76
, pp. 168-177
-
-
Feld, J.J.1
Colledge, D.2
Sozzi, V.3
Edwards, R.4
Littlejohn, M.5
Locarnini, S.A.6
-
19
-
-
78650580448
-
Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators
-
Katen SP, Chirapu SR, Finn M.G., Zlotnick A. 2010. Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators. ACS Chem Biol 5:1125-1136. http://dx.doi.org/10.1021/cb100275b.
-
(2010)
ACS Chem Biol
, vol.5
, pp. 1125-1136
-
-
Katen, S.P.1
Chirapu, S.R.2
Finn, M.G.3
Zlotnick, A.4
-
20
-
-
0036721178
-
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro
-
Delaney WE, IV, Edwards R, Colledge D, Shaw T, Furman P, Painter G, Locarnini S. 2002. Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro. Antimicrob Agents Chemother 46:3057-3060. http://dx.doi.org/10.1128/AAC.46.9.3057-3060.2002.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3057-3060
-
-
Delaney WE, I.V.1
Edwards, R.2
Colledge, D.3
Shaw, T.4
Furman, P.5
Painter, G.6
Locarnini, S.7
-
21
-
-
0031758695
-
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3=-thiacytidine
-
King RW, Ladner SK, Miller T.J., Zaifert K., Perni RB, Conway SC, Otto MJ. 1998. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3=-thiacytidine. Antimicrob Agents Chemother 42:3179-3186.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 3179-3186
-
-
King, R.W.1
Ladner, S.K.2
Miller, T.J.3
Zaifert, K.4
Perni, R.B.5
Conway, S.C.6
Otto, M.J.7
-
22
-
-
0034606451
-
Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication
-
Perni RB, Conway SC, Ladner S.K., Zaifert K., Otto MJ, King RW. 2000. Phenylpropenamide derivatives as inhibitors of hepatitis B virus replication. Bioorg Med Chem Lett 10:2687-2690. http://dx.doi.org/10.1016/S0960-894X(00)00544-8.
-
(2000)
Bioorg Med Chem Lett
, vol.10
, pp. 2687-2690
-
-
Perni, R.B.1
Conway, S.C.2
Ladner, S.K.3
Zaifert, K.4
Otto, M.J.5
King, R.W.6
-
23
-
-
33750704335
-
Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1
-
Bourne CR, Finn MG, Zlotnick A. 2006. Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1. J Virol 80:11055-11061. http://dx.doi.org/10.1128/JVI.00933-06.
-
(2006)
J Virol
, vol.80
, pp. 11055-11061
-
-
Bourne, C.R.1
Finn, M.G.2
Zlotnick, A.3
-
24
-
-
34547425435
-
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
-
Lok AS, Zoulim F, Locarnini S., Bartholomeusz A, Ghany MG, Pawlotsky J.M., Liaw YF, Mizokami M, Kuiken C; Hepatitis B Virus Drug Resistance Working Group. 2007. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46:254-265. http://dx.doi.org/10.1002/hep.21698.
-
(2007)
Hepatology
, vol.46
, pp. 254-265
-
-
Lok, A.S.1
Zoulim, F.2
Locarnini, S.3
Bartholomeusz, A.4
Ghany, M.G.5
Pawlotsky, J.M.6
Liaw, Y.F.7
Mizokami, M.8
Kuiken, C.9
-
25
-
-
84895556462
-
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation
-
Yang L, Shi LP, Chen H.J., Tong XK, Wang GF, Zhang YM, Wang W.L., Feng CL, He PL, Zhu FH, Hao Y.H., Wang BJ, Yang DL, Tang W, Nan F.J., Zuo JP. 2014. Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation. Acta Pharmacol Sin 35:410-418. http://dx.doi.org/10.1038/aps.2013.175.
-
(2014)
Acta Pharmacol Sin
, vol.35
, pp. 410-418
-
-
Yang, L.1
Shi, L.P.2
Chen, H.J.3
Tong, X.K.4
Wang, G.F.5
Zhang, Y.M.6
Wang, W.L.7
Feng, C.L.8
He, P.L.9
Zhu, F.H.10
Hao, Y.H.11
Wang, B.J.12
Yang, D.L.13
Tang, W.14
Nan, F.J.15
Zuo, J.P.16
-
26
-
-
70349736166
-
Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system
-
Newman M, Chua PK, Tang F.M., Su PY, Shih C. 2009. Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system. J Virol 83:10616-10626. http://dx.doi.org/10.1128/JVI.00749-09.
-
(2009)
J Virol
, vol.83
, pp. 10616-10626
-
-
Newman, M.1
Chua, P.K.2
Tang, F.M.3
Su, P.Y.4
Shih, C.5
-
27
-
-
0000934401
-
Production of hepatitis B virus particles in hep G2 cells transfected with cloned hepatitis B virus DNA
-
Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84:1005-1009. http://dx.doi.org/10.1073/pnas.84.4.1005.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 1005-1009
-
-
Sells, M.A.1
Chen, M.L.2
Acs, G.3
-
28
-
-
0036315270
-
Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment
-
Abdelhamed AM, Kelley CM, Miller T.G., Furman PA, Isom HC. 2002. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol 76:8148-8160. http://dx.doi.org/10.1128/JVI.76.16.8148-8160.2002.
-
(2002)
J Virol
, vol.76
, pp. 8148-8160
-
-
Abdelhamed, A.M.1
Kelley, C.M.2
Miller, T.G.3
Furman, P.A.4
Isom, H.C.5
-
29
-
-
33846918244
-
Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment
-
Guan SH, Lu M, Grunewald P., Roggendorf M, Gerken G, Schlaak JF 2007. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol 13:228-235. http://dx.doi.org/10.3748/wjg.v13.i2.228.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 228-235
-
-
Guan, S.H.1
Lu, M.2
Grunewald, P.3
Roggendorf, M.4
Gerken, G.5
Schlaak, J.F.6
-
30
-
-
70350322303
-
Functional surfaces of the hepatitis B virus capsid
-
Pairan A, Bruss V. 2009. Functional surfaces of the hepatitis B virus capsid. J Virol 83:11616-11623. http://dx.doi.org/10.1128/JVI.01178-09.
-
(2009)
J Virol
, vol.83
, pp. 11616-11623
-
-
Pairan, A.1
Bruss, V.2
-
31
-
-
79959562500
-
Kruppel-like factor 15 activates hepatitis B virus gene expression and replication
-
Zhou J, Tan T, Tian Y., Zheng B, Ou JH, Huang E.J., Yen TS. 2011. Kruppel-like factor 15 activates hepatitis B virus gene expression and replication. Hepatology 54:109-121. http://dx.doi.org/10.1002/hep.24362.
-
(2011)
Hepatology
, vol.54
, pp. 109-121
-
-
Zhou, J.1
Tan, T.2
Tian, Y.3
Zheng, B.4
Ou, J.H.5
Huang, E.J.6
Yen, T.S.7
-
32
-
-
84878588315
-
Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids
-
Campagna MR, Liu F, Mao R., Mills C, Cai D, Guo F., Zhao X, Ye H, Cuconati A., Guo H, Chang J, Xu X., Block TM, Guo JT. 2013. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids. J Virol 87:6931-6942. http://dx.doi.org/10.1128/JVI.00582-13.
-
(2013)
J Virol
, vol.87
, pp. 6931-6942
-
-
Campagna, M.R.1
Liu, F.2
Mao, R.3
Mills, C.4
Cai, D.5
Guo, F.6
Zhao, X.7
Ye, H.8
Cuconati, A.9
Guo, H.10
Chang, J.11
Xu, X.12
Block, T.M.13
Guo, J.T.14
-
33
-
-
0028358552
-
Multiple functions of capsid protein phosphorylation in Duck hepatitis B virus replication
-
Yu M, Summers J. 1994. Multiple functions of capsid protein phosphorylation in duck hepatitis B virus replication. J Virol 68:4341-4348.
-
(1994)
J Virol
, vol.68
, pp. 4341-4348
-
-
Yu, M.1
Summers, J.2
-
34
-
-
33745207098
-
Native hepatitis B virions and capsids visualized by electron cryomicroscopy
-
Dryden KA, Wieland SF, Whitten-Bauer C, Gerin J.L., Chisari FV, Yeager M. 2006. Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol Cell 22:843-850. http://dx.doi.org/10.1016/j.molcel.2006.04.025.
-
(2006)
Mol Cell
, vol.22
, pp. 843-850
-
-
Dryden, K.A.1
Wieland, S.F.2
Whitten-Bauer, C.3
Gerin, J.L.4
Chisari, F.V.5
Yeager, M.6
-
35
-
-
84899625639
-
Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion
-
Xu YB, Yang L, Wang G.F., Tong XK, Wang YJ, Yu Y, Jing J.F., Feng CL, He PL, Lu W, Tang W., Zuo JP. 2014. Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion. Antiviral Res 107:6-15. http://dx.doi.org/10.1016/j.antiviral.2014.04.002.
-
(2014)
Antiviral Res
, vol.107
, pp. 6-15
-
-
Xu, Y.B.1
Yang, L.2
Wang, G.F.3
Tong, X.K.4
Wang, Y.J.5
Yu, Y.6
Jing, J.F.7
Feng, C.L.8
He, P.L.9
Lu, W.10
Tang, W.11
Zuo, J.P.12
-
36
-
-
80053460800
-
Secretion of genome-free hepatitis B virus-single strand blocking model for virion morphogenesis of para-retrovirus
-
Ning X, Nguyen D, Mentzer L., Adams C, Lee H, Ashley R., Hafenstein S, Hu J. 2011. Secretion of genome-free hepatitis B virus-single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog 7:e1002255. http://dx.doi.org/10.1371/journal.ppat.1002255.
-
(2011)
PLoS Pathog
, vol.7
-
-
Ning, X.1
Nguyen, D.2
Mentzer, L.3
Adams, C.4
Lee, H.5
Ashley, R.6
Hafenstein, S.7
Hu, J.8
-
37
-
-
0016744698
-
Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus
-
Gerin JL, Ford EC, Purcell RH 1975. Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. Am J Pathol 81:651-668.
-
(1975)
Am J Pathol
, vol.81
, pp. 651-668
-
-
Gerin, J.L.1
Ford, E.C.2
Purcell, R.H.3
-
39
-
-
84867882831
-
Host factors involved in hepatitis B virus maturation, assembly, and egress
-
Prange R. 2012. Host factors involved in hepatitis B virus maturation, assembly, and egress. Med Microbiol Immunol 201:449-461. http://dx.doi.org/10.1007/s00430-012-0267-9.
-
(2012)
Med Microbiol Immunol
, vol.201
, pp. 449-461
-
-
Prange, R.1
-
40
-
-
0032845490
-
Hepatitis B virus replication: Novel roles for virushost interactions
-
Nassal M. 1999. Hepatitis B virus replication: novel roles for virushost interactions. Intervirology 42:100-116. http://dx.doi.org/10.1159/000024970.
-
(1999)
Intervirology
, vol.42
, pp. 100-116
-
-
Nassal, M.1
-
41
-
-
0026493753
-
The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis
-
Wang GH, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663-670. http://dx.doi.org/10.1016/0092-8674(92)90599-8.
-
(1992)
Cell
, vol.71
, pp. 663-670
-
-
Wang, G.H.1
Seeger, C.2
-
42
-
-
67749099788
-
Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation
-
Kim S, Lee J, Ryu WS 2009. Four conserved cysteine residues of the hepatitis B virus polymerase are critical for RNA pregenome encapsidation. J Virol 83:8032-8040. http://dx.doi.org/10.1128/JVI.00332-09.
-
(2009)
J Virol
, vol.83
, pp. 8032-8040
-
-
Kim, S.1
Lee, J.2
Ryu, W.S.3
-
43
-
-
33749080545
-
Stable HepG2- and huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus
-
Sun D, Nassal M. 2006. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45:636-645. http://dx.doi.org/10.1016/j.jhep.2006.05.019.
-
(2006)
J Hepatol
, vol.45
, pp. 636-645
-
-
Sun, D.1
Nassal, M.2
-
44
-
-
34347223650
-
Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue
-
Ying C, Li Y, Leung C.H., Robek MD, Cheng YC. 2007. Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proc Natl Acad Sci U S A 104:8526-8531. http://dx.doi.org/10.1073/pnas.0609883104.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 8526-8531
-
-
Ying, C.1
Li, Y.2
Leung, C.H.3
Robek, M.D.4
Cheng, Y.C.5
-
45
-
-
79952633994
-
Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner
-
Bardens A, Doring T, Stieler J., Prange R. 2011. Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner. Cell Microbiol 13:602-619. http://dx.doi.org/10.1111/j.1462-5822.2010.01557.x.
-
(2011)
Cell Microbiol
, vol.13
, pp. 602-619
-
-
Bardens, A.1
Doring, T.2
Stieler, J.3
Prange, R.4
-
46
-
-
84940515778
-
Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion
-
Yan R, Zhao X, Cai D., Liu Y, Block T, Guo J.T., Guo H. 2015. Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion. J Virol http://dx.doi.org/10.1128/JVI.00933-15.
-
(2015)
J Virol
-
-
Yan, R.1
Zhao, X.2
Cai, D.3
Liu, Y.4
Block, T.5
Guo, J.T.6
Guo, H.7
-
47
-
-
84930508017
-
Genomefree hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy
-
Luckenbaugh L, Kitrinos KM, Delaney W.E., IV, Hu J. 2015. Genomefree hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy. J Viral Hepat 22:561-570. http://dx.doi.org/10.1111/jvh.12361.
-
(2015)
J Viral Hepat
, vol.22
, pp. 561-570
-
-
Luckenbaugh, L.1
Kitrinos, K.M.2
Delaney Iv, W.E.3
Hu, J.4
|